Global Myasthenia Gravis Treatment Market: Forecast and Trends

Report Code: PHM280A

Publish Date: Dec 2023

Publisher: BCC Publishing

Category: Pharmaceuticals

Download Report Overview

30% Off

Limited Period Offer

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for myasthenia gravis treatment is estimated to increase from $1.3 billion in 2023 to reach $2.2 billion by 2028, at a compound annual growth rate (CAGR) of 10.5% from 2023 through 2028.

Report Includes

  • 54 data tables and 47 additional tables
  • An overview and analysis of the global market for myasthenia gravis (MG) treatments
  • Analyses of market trends, with historical market revenue data (sales figures) for 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimates of the market size, revenue forecasts and potential growth share analysis for MG treatments based on product, type, treatment modality, and region
  • In-depth information (facts and figures) pertaining to the major factors influencing the market (drivers, restraints, opportunities and challenges)
  • Analysis of the market growth opportunities through Porter’s Five Forces and PESTLE analyses, taking into consideration the prevailing micro- and macro environmental factors
  • An examination of the importance of ESG in the myasthenia gravis market, taking into account consumer attitudes, risks and opportunities, and the ESG practices of pharmaceutical and biotech companies
  • Discussion of the factors driving the market, industry trends and new developments
  • Analysis of relevant patents
  • Identification of the leaders in the field of MG
  • Profiles of the leading market players, including Profiles of the leading market players, including AbbVie, Bausch Health, Gilead Sciences, Merck & Co. Inc., Servier, and Teva

Report Scope

This report aims to study the myasthenia gravis treatment global market size comprehensively. Current and historical market revenues can be estimated based on the product type, treatment by drug and region.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $1.2 billion
Market size forecast $2.2 billion
Growth rate CAGR of 10.5% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Product, Type, Treatment Modality, and Geographic Region
Regions covered North America, Europe, and Asia-Pacific
Countries covered U.S., Canada, Germany, France, UK, Italy, Spain, Russia, China, India, Australia, and Japan
Key Market Drivers
  • Medical advancements.
  • Affordability of therapies.
  • Rising awareness.
Companies studied
ASTELLAS PHARMA INC.ASTRAZENECA
ABBVIE INC.AMYASTHENIA GRAVISEN INC.
BAUSCH HEALTH COMPANIES INC.BAYER AG
BIOGENBRISTOL-MYERS SQUIBB CO.
CSLDAIICHI SANKYO CO. LTD.
F. HOFFMANN-LA ROCHE LTD.GILEAD SCIENCES INC.
GSK PLC.MERCK & CO. INC.
NOVARTIS AGPFIZER INC.
SANOFILES LABORATOIRES SERVIER
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The global Myasthenia Gravis market is projected to grow from $1.2 billion in 2022 to $2.1 billion in 2028 at a compound annual growth rate (CAGR) of 10.5 % during the forecast period.
The expansion of the Myasthenia Gravis market is propelled by the advancement of treatment strategies, encompassing innovative therapies and tailored approaches. The growing awareness within both medical practitioners and patients plays a pivotal role in enabling timely diagnosis and intervention. Additionally, the increasing prevalence of Myasthenia Gravis drives the demand for a more comprehensive array of treatment choices. Ongoing research endeavors and collaborative initiatives further contribute to an enhanced understanding of therapeutics, fostering innovation in the field.
The Myasthenia Gravis market is segmented based on the product, type, treatment modality, and geographic region.
The Monoclonal antibody segment will dominate the market by the end of 2028.
North America holds the highest share in the market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Melissa Dueck brings more than 25 years of health industry experience to the consulting analyst role with expertise in pharmaceuticals, medical technologies, and hospital operations. Ms. Dueck holds an MBA in Health Care Management, an MPH in Global Health, and is a pending doctoral candidate. She has authored several industry-specific documents and is a well-respected, trusted contributor to the market intelligence community. Her writings are published in magazines, newspapers, and professional journals. She is also an experienced custom market research writer who has worked with a large variety of clients in many fields who require innumerable variations to research documents. Ms. Dueck serves the health and medical community through emergency room medical training, healthcare information system coordination, program implementation and evaluations, and strategic business oversight planning.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Myasthenia Gravis Treatment Market: Forecast and Trends120Free
Chapter- 1: Introduction3Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Market Overview10Free
Chapter- 4: Market Dynamics11Free
Chapter- 5: Market Breakdown by Region8Free
Chapter- 6: Market Breakdown by Type4Free
Chapter- 7: Market Breakdown by Treatment Modality3Free
Chapter- 8: Market Breakdown by Type of Product6Free
Chapter- 9: ESG Development9Free
Chapter- 10: Emerging Technologies and Developments2Free
Chapter- 11: Competitive Intelligence5Free
Chapter- 12: Patent Analysis5Free
Chapter- 13: Pipeline Analysis4Free
Chapter- 14: M&A and Venture Funding Outlook2Free
Chapter- 15: Company Profiles42Free
Chapter- 16: Appendix: Acronyms2Free

Related Reports

Autoimmune Disease Diagnostics: Global Markets

Published - Jan 2024 | Publisher - BCC Publishing | Code - PHM160C

The global market for autoimmune disease diagnostics is estimated to increase from $14.8 billion in 2023 to reach $17.9 billion by 2028, at a compound annual growth rate (CAGR) of 3.9% from 2023 through 2028.

Immunotherapy Drugs: Global Markets

Published - Apr 2021 | Publisher - BCC Publishing | Code - PHM249A

The global market for immunotherapy drugs should grow from $139.8 billion in 2020 to $204.4 billion by 2025, at compound annual growth rate (CAGR) of 7.9% for the period of 2020-2025.

Autoimmune Disorder Therapies: Global Markets

Published - Nov 2020 | Publisher - BCC Publishing | Code - PHM240A

The global market for autoimmune disorder therapies should grow from $53.2 billion in 2019 to $90.7 billion by 2024 with a compound annual growth rate (CAGR) of 11.2% for the period of 2019-2024.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 101

  • Summary Table: Global Market for the Treatment of Myasthenia Gravis, by Type of Myasthenia Gravis, Through 2028
  • Table 1: Global Population, Aged 60+, 2010-2050
  • Table 2: Factors Leading to the Increasing Incidence of Myasthenia Gravis Worldwide
  • Table 3: Global Serological Testing for Myasthenia Gravis, by Type
  • Table 4: Targeted Drug Therapies for the Treatment of Myasthenia Gravis
  • Table 5: Diagnostic Challenges in the Treatment of Myasthenia Gravis
  • Table 6: Risks of Emerging Therapies for Myasthenia Gravis, by Type
  • Table 7: Global Market for the Treatment of Myasthenia Gravis, by Region, Through 2028
  • Table 8: North American Market for the Treatment of Myasthenia Gravis, by Country, Through 2028
  • Table 9: European Market for the Treatment of Myasthenia Gravis, by Country, Through 2028
  • Table 10: Asia-Pacific Market for the Treatment of Myasthenia Gravis, by Country, Through 2028
Sample Report

Recent Reports

Over-the-Counter (OTC) Drugs, and Vitamins & Dietary Supplements: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - PHM050D

The global market for over-the- counter (OTC) drugs, vitamins and dietary supplements is expected to grow from $276.9 billion in 2025 and is projected to reach $371.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2025 to 2030.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

The Global Influenza Market

Published - May 2025 | Publisher - BCC Publishing | Code - PHM049F

The global influenza market is expected to grow from $9.0 billion in 2024 and is projected to reach $12.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.2% during the forecast period of 2024 to 2029. 

Liver Disease Treatments: The Global Market

Published - Apr 2025 | Publisher - BCC Publishing | Code - PHM057D

The global market for liver disease treatments is estimated to increase from $46.0 billion in 2024 to reach $69.1 billion by 2030, at a compound annual growth rate (CAGR) of 7.1% from 2025 through 2030.

Cancer Immunotherapy: Technologies and Global Markets

Published - Apr 2025 | Publisher - BCC Publishing | Code - PHM129C

The global cancer immunotherapy market is expected to grow from $144.2 billion in 2024 and is projected to reach $247.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.4% during the forecast period of 2024 to 2029.

Top Trending Reports

Next-Generation Advanced Batteries: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - FCB062B

The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Global Markets for Emerging Medical Device Technologies

Published - Mar 2025 | Publisher - BCC Publishing | Code - HLC191C

The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Myasthenia Gravis Treatment Market: Forecast and Trends
Sample Report